Aenitis Technologies secures €14.5M for commercial expansion of acoustofluidic technology in bioproduction.

Aenitis Technologies has secured significant funding from the European Innovation Council Fund, Quadrivium I, and Mifani Invest, totaling €14.5 million. This investment will drive the commercial launch and global expansion of its acoustofluidic technology, which offers scalable and precise cell processing solutions for the bioproduction industry. The funds will also support the final development stages of its CE-marked product, Mitis™, and establish distribution channels in key markets.

October 10, 2024
3 Articles

Further Reading